Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03803696 · ClinicalTrials.gov registry record · NA
Multimodal Sexual Dysfunction Intervention In HCT
A NA study of Hematopoietic Stem Cell Transplantation and Sexual Dysfunction, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 230
- Enrollment target
- 1
- Study location
NCT03803696: Active NA study of Hematopoietic Stem Cell Transplantation and Sexual Dysfunction, sponsored by Massachusetts General Hospital.
NCT03803696 is a NA study of Hematopoietic Stem Cell Transplantation and Sexual Dysfunction that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 230 participants, below the 9,781-participant average among 26 other Hematopoietic Stem Cell Transplantation trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03803696, a NA study of Hematopoietic Stem Cell Transplantation and Sexual Dysfunction, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is evaluating the impact of an intervention to improve sexual function in stem cell transplant survivors on participants' sexual function, quality of life, and mood. It is expected that about 120 people who have undergone a stem cell transplant will take part in this research study.
Primary Outcome
compare patients' global satisfaction with sex using PROMIS Sexual Function and Satisfaction Measure (global satisfaction domain) at three months between the study groups using linear regression controlling for baseline values (as necessary for any imbalances in baseline variables
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Standard Care
- BEHAVIORAL Multimodal Intervention to Address Sexual Dysfunction
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT03803696 still lists
NCT03803696 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 9,781-participant average among 26 other Hematopoietic Stem Cell Transplantation trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Hematopoietic Stem Cell Transplantation appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Standard Care is the first listed.
NCT03803696 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03803696 about?
NCT03803696 is a clinical study titled "Multimodal Sexual Dysfunction Intervention In HCT". This research study is evaluating the impact of an intervention to improve sexual function in stem cell transplant survivors on participants' sexual function, quality of life, and mood. It is expected that about 120 people who have undergone a stem cell transplant will take part in this research st...
What is the current status of trial NCT03803696?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 230 participants. The study started on 2019-02-01. Estimated completion is 2025-12-31.
What conditions does trial NCT03803696 study?
This clinical trial studies the following conditions: Hematopoietic Stem Cell Transplantation, Sexual Dysfunction, Hematologic Diseases.
What interventions are being tested in trial NCT03803696?
The interventions under investigation include: Enhanced Standard Care (BEHAVIORAL), Multimodal Intervention to Address Sexual Dysfunction (BEHAVIORAL).
Who is sponsoring clinical trial NCT03803696?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03803696 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoietic Stem Cell Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03803696's enrollment target sits among peer trials
230 5th of 26 higher than 22 of 26 other Hematopoietic Stem Cell Transplantation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hematopoietic Stem Cell Transplantation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Employment Support After Hematopoietic Stem Cell Transplantation
RECRUITING · NA
-
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
RECRUITING · NA
-
Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant
RECRUITING · NA
-
αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)
RECRUITING · NA
-
Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
RECRUITING · NA
-
Art and Physical Therapy in Pediatric HCT
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI